Neuropeptide Y

vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage

Peter W. Abel, Chide Han, Bryan D. Noe, John K. McDonald

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The possible role of neuropeptide Y (NPY) as a vasoconstrictor substance contributing to the development of cerebral vasospasm after experimental subarachnoid hemorrhage was studied. Autologous blood was injected into the cisterna magna of control rabbits and rabbits that had received bilateral superior cervical ganglionectomy 2 days before blood injection. The days after blood injection the concentration of NPY in cerebrospinal fluid (CSF) was 5971 ± 551 pg/ml while CSF from control animals contained 992 ± 162 pg/ml of NPY. The effects of porcine NPY on norepinephrine-induced contraction of rabbit cerebral arteries were also studied in vitro. NPY (1.2 nM) caused a 3-fold potentiation of norepinephrine-induced contraction of cerebral arteries. CSF from control rabbits diluted by 50% with Krebs solution had no significant effect on norepinephrine-induced contraction of cerebral arteries when compared to responses in Krebs solution only; however, diluted CSF from denervated blood-injected rabbits potentiated norepinephrine-induced contraction by 2.6-fold. Antiserum containing NPY specific antibodies was used to immunoprecipitate the peptide from CSF taken from denervated blood-injected rabbits. CSF treated with this antiserum contained less than 40 pg/ml of NPY and had no effect on norepinephrine-induced contraction of cerebral arteries. These results show that the concentration of NPY in CSF of rabbits is elevated after experimetal subarachnoid hemorrhage. In addition, NPY in CSF can potentiate the vasoconstrictor effect of norepinephrine which may contribute to the development of cerebral vasospasm.

Original languageEnglish
Pages (from-to)250-258
Number of pages9
JournalBrain Research
Volume463
Issue number2
DOIs
StatePublished - Nov 1 1988

Fingerprint

Intracranial Vasospasm
Neuropeptide Y
Vasoconstrictor Agents
Subarachnoid Hemorrhage
Cerebrospinal Fluid
Norepinephrine
Cerebral Arteries
Rabbits
Immune Sera
Ganglionectomy
Cisterna Magna
Injections
Swine
Peptides

All Science Journal Classification (ASJC) codes

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Neuropeptide Y : vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage. / Abel, Peter W.; Han, Chide; Noe, Bryan D.; McDonald, John K.

In: Brain Research, Vol. 463, No. 2, 01.11.1988, p. 250-258.

Research output: Contribution to journalArticle

@article{bf2c44fd670b45fea5562b8bf813fe40,
title = "Neuropeptide Y: vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage",
abstract = "The possible role of neuropeptide Y (NPY) as a vasoconstrictor substance contributing to the development of cerebral vasospasm after experimental subarachnoid hemorrhage was studied. Autologous blood was injected into the cisterna magna of control rabbits and rabbits that had received bilateral superior cervical ganglionectomy 2 days before blood injection. The days after blood injection the concentration of NPY in cerebrospinal fluid (CSF) was 5971 ± 551 pg/ml while CSF from control animals contained 992 ± 162 pg/ml of NPY. The effects of porcine NPY on norepinephrine-induced contraction of rabbit cerebral arteries were also studied in vitro. NPY (1.2 nM) caused a 3-fold potentiation of norepinephrine-induced contraction of cerebral arteries. CSF from control rabbits diluted by 50{\%} with Krebs solution had no significant effect on norepinephrine-induced contraction of cerebral arteries when compared to responses in Krebs solution only; however, diluted CSF from denervated blood-injected rabbits potentiated norepinephrine-induced contraction by 2.6-fold. Antiserum containing NPY specific antibodies was used to immunoprecipitate the peptide from CSF taken from denervated blood-injected rabbits. CSF treated with this antiserum contained less than 40 pg/ml of NPY and had no effect on norepinephrine-induced contraction of cerebral arteries. These results show that the concentration of NPY in CSF of rabbits is elevated after experimetal subarachnoid hemorrhage. In addition, NPY in CSF can potentiate the vasoconstrictor effect of norepinephrine which may contribute to the development of cerebral vasospasm.",
author = "Abel, {Peter W.} and Chide Han and Noe, {Bryan D.} and McDonald, {John K.}",
year = "1988",
month = "11",
day = "1",
doi = "10.1016/0006-8993(88)90397-6",
language = "English",
volume = "463",
pages = "250--258",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Neuropeptide Y

T2 - vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage

AU - Abel, Peter W.

AU - Han, Chide

AU - Noe, Bryan D.

AU - McDonald, John K.

PY - 1988/11/1

Y1 - 1988/11/1

N2 - The possible role of neuropeptide Y (NPY) as a vasoconstrictor substance contributing to the development of cerebral vasospasm after experimental subarachnoid hemorrhage was studied. Autologous blood was injected into the cisterna magna of control rabbits and rabbits that had received bilateral superior cervical ganglionectomy 2 days before blood injection. The days after blood injection the concentration of NPY in cerebrospinal fluid (CSF) was 5971 ± 551 pg/ml while CSF from control animals contained 992 ± 162 pg/ml of NPY. The effects of porcine NPY on norepinephrine-induced contraction of rabbit cerebral arteries were also studied in vitro. NPY (1.2 nM) caused a 3-fold potentiation of norepinephrine-induced contraction of cerebral arteries. CSF from control rabbits diluted by 50% with Krebs solution had no significant effect on norepinephrine-induced contraction of cerebral arteries when compared to responses in Krebs solution only; however, diluted CSF from denervated blood-injected rabbits potentiated norepinephrine-induced contraction by 2.6-fold. Antiserum containing NPY specific antibodies was used to immunoprecipitate the peptide from CSF taken from denervated blood-injected rabbits. CSF treated with this antiserum contained less than 40 pg/ml of NPY and had no effect on norepinephrine-induced contraction of cerebral arteries. These results show that the concentration of NPY in CSF of rabbits is elevated after experimetal subarachnoid hemorrhage. In addition, NPY in CSF can potentiate the vasoconstrictor effect of norepinephrine which may contribute to the development of cerebral vasospasm.

AB - The possible role of neuropeptide Y (NPY) as a vasoconstrictor substance contributing to the development of cerebral vasospasm after experimental subarachnoid hemorrhage was studied. Autologous blood was injected into the cisterna magna of control rabbits and rabbits that had received bilateral superior cervical ganglionectomy 2 days before blood injection. The days after blood injection the concentration of NPY in cerebrospinal fluid (CSF) was 5971 ± 551 pg/ml while CSF from control animals contained 992 ± 162 pg/ml of NPY. The effects of porcine NPY on norepinephrine-induced contraction of rabbit cerebral arteries were also studied in vitro. NPY (1.2 nM) caused a 3-fold potentiation of norepinephrine-induced contraction of cerebral arteries. CSF from control rabbits diluted by 50% with Krebs solution had no significant effect on norepinephrine-induced contraction of cerebral arteries when compared to responses in Krebs solution only; however, diluted CSF from denervated blood-injected rabbits potentiated norepinephrine-induced contraction by 2.6-fold. Antiserum containing NPY specific antibodies was used to immunoprecipitate the peptide from CSF taken from denervated blood-injected rabbits. CSF treated with this antiserum contained less than 40 pg/ml of NPY and had no effect on norepinephrine-induced contraction of cerebral arteries. These results show that the concentration of NPY in CSF of rabbits is elevated after experimetal subarachnoid hemorrhage. In addition, NPY in CSF can potentiate the vasoconstrictor effect of norepinephrine which may contribute to the development of cerebral vasospasm.

UR - http://www.scopus.com/inward/record.url?scp=0023803476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023803476&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(88)90397-6

DO - 10.1016/0006-8993(88)90397-6

M3 - Article

VL - 463

SP - 250

EP - 258

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -